ARWR logo

ARWR Stock Overview

Profile

Full Name:

Arrowhead Pharmaceuticals, Inc.

Sector:

Healthcare

Industry:

Biotechnology

Country:

United States

IPO:

December 16, 1993

Indexes:

Not included

Description:

Arrowhead Pharmaceuticals, Inc. is a biopharmaceutical company focused on developing innovative drugs for the treatment of genetically based diseases. Current clinical developments are focused on treating liver diseases, lung diseases, and malignant tumors. The company was founded in 1989 and is headquartered in Pasadena, California. Despite its considerable experience in the industry, Arrowhead Pharmaceuticals Inc. is still in the early stages of drug development. The research facilities of Arrowhead are located in Madison, Wisconsin. The company does not own any real estate, as its office and research center are leased.

Key Details

Price

$19.77

Annual Revenue

$3.55 M(-98.52% YoY)

Annual EPS

-$5.00(-160.42% YoY)

Annual ROE

-250.72%

Beta

1.59

Events Calendar

Earnings

Next earnings date:

May 9, 2025

Recent quarterly earnings:

Feb 10, 2025

Recent annual earnings:

Nov 26, 2024
Dividend

Next ex-dividend date:

N/A

Recent ex-dividend date:

N/A
Splits

Next split:

N/A

Recent split:

Nov 17, 2011

Analyst ratings

Recent major analysts updates

Feb 14, 25 B. Riley Securities
Buy
Feb 12, 25 HC Wainwright & Co.
Buy
Feb 11, 25 RBC Capital
Outperform
Feb 11, 25 Chardan Capital
Buy
Jan 23, 25 HC Wainwright & Co.
Buy
Jan 22, 25 HC Wainwright & Co.
Buy
Dec 20, 24 HC Wainwright & Co.
Buy
Dec 12, 24 Chardan Capital
Buy
Dec 3, 24 HC Wainwright & Co.
Buy
Nov 29, 24 Bernstein
Market Perform

Market Data

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Price

Market cap

Technical

Dividend

Profitability

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Profit

EPS

ROA & ROE

EBIT & EBITDA

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PB Ratio

PS Ratio

Enterprise value

EV/EBITDA

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Leverage

Risk & Stability

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Equity

Liabilities

Debt

Expenses

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cash Flow

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Free CashFlow

CAPEX

Institutional Ownership

FAQ

  • What is the ticker symbol for Arrowhead Pharmaceuticals?
  • Does Arrowhead Pharmaceuticals pay dividends?
  • What sector is Arrowhead Pharmaceuticals in?
  • What industry is Arrowhead Pharmaceuticals in?
  • What country is Arrowhead Pharmaceuticals based in?
  • When did Arrowhead Pharmaceuticals go public?
  • Is Arrowhead Pharmaceuticals in the S&P 500?
  • Is Arrowhead Pharmaceuticals in the NASDAQ 100?
  • Is Arrowhead Pharmaceuticals in the Dow Jones?
  • When was Arrowhead Pharmaceuticals's last earnings report?
  • When does Arrowhead Pharmaceuticals report earnings?
  • Should I buy Arrowhead Pharmaceuticals stock now?

What is the ticker symbol for Arrowhead Pharmaceuticals?

The ticker symbol for Arrowhead Pharmaceuticals is NASDAQ:ARWR

Does Arrowhead Pharmaceuticals pay dividends?

No, Arrowhead Pharmaceuticals does not pay dividends

What sector is Arrowhead Pharmaceuticals in?

Arrowhead Pharmaceuticals is in the Healthcare sector

What industry is Arrowhead Pharmaceuticals in?

Arrowhead Pharmaceuticals is in the Biotechnology industry

What country is Arrowhead Pharmaceuticals based in?

Arrowhead Pharmaceuticals is headquartered in United States

When did Arrowhead Pharmaceuticals go public?

Arrowhead Pharmaceuticals's initial public offering (IPO) was on December 16, 1993

Is Arrowhead Pharmaceuticals in the S&P 500?

No, Arrowhead Pharmaceuticals is not included in the S&P 500 index

Is Arrowhead Pharmaceuticals in the NASDAQ 100?

No, Arrowhead Pharmaceuticals is not included in the NASDAQ 100 index

Is Arrowhead Pharmaceuticals in the Dow Jones?

No, Arrowhead Pharmaceuticals is not included in the Dow Jones index

When was Arrowhead Pharmaceuticals's last earnings report?

Arrowhead Pharmaceuticals's most recent earnings report was on Feb 10, 2025

When does Arrowhead Pharmaceuticals report earnings?

The next expected earnings date for Arrowhead Pharmaceuticals is May 9, 2025

Should I buy Arrowhead Pharmaceuticals stock now?

As of today, analysts generally recommend a 'Buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions